1-10 of 10
Andrew V. Schally
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer

Available to Purchase
Stephen V. Liu, Denice D. Tsao-Wei, Shigang Xiong, Susan Groshen, Tanya B. Dorff, David I. Quinn, Yu-Chong Tai, Juergen Engel, Debra Hawes, Andrew V. Schally, Jacek K. Pinski
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (24): 6277–6283.
https://doi.org/10.1158/1078-0432.CCR-14-0489
Published: 14 December 2014
View articletitled, Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer
Open the PDF for Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists

Available to Purchase
Stephen V. Liu, Andrew V. Schally, Debra Hawes, Shigang Xiong, Laden Fazli, Martin Gleave, Jie Cai, Susan Groshen, Frank Brands, Juergen Engel, Jacek Pinski
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (18): 4675–4680.
https://doi.org/10.1158/1078-0432.CCR-10-1113
Published: 14 September 2010
View articletitled, Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists
Open the PDF for Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists in another window
Journal Articles

Receptors for Luteinizing Hormone Releasing Hormone Expressed on Human Renal Cell Carcinomas Can Be Used for Targeted Chemotherapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogues

Available to Purchase
Gunhild Keller, Andrew V. Schally, Timo Gaiser, Attila Nagy, Benjamin Baker, Gabor Halmos, Jörg B. Engel
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5549–5557.
https://doi.org/10.1158/1078-0432.CCR-04-2464
Published: 01 August 2005
View articletitled, Receptors for Luteinizing Hormone Releasing Hormone Expressed on Human Renal Cell Carcinomas Can Be Used for Targeted Chemotherapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogues
Open the PDF for Receptors for Luteinizing Hormone Releasing Hormone Expressed on Human Renal Cell Carcinomas Can Be Used for Targeted Chemotherapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogues in another window
Journal Articles

Effective Inhibition of Experimental Human Ovarian Cancers with a Targeted Cytotoxic Bombesin Analogue AN-215

Available to Purchase
Jörg B. Engel, Gunhild Keller, Andrew V. Schally, Gabor Halmos, Brian Hammann, Attila Nagy
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (6): 2408–2415.
https://doi.org/10.1158/1078-0432.CCR-04-1670
Published: 23 March 2005
View articletitled, Effective Inhibition of Experimental Human Ovarian Cancers with a Targeted Cytotoxic Bombesin Analogue AN-215
Open the PDF for Effective Inhibition of Experimental Human Ovarian Cancers with a Targeted Cytotoxic Bombesin Analogue AN-215 in another window
Journal Articles

Inhibitory Effect of Antagonists of Bombesin and Growth Hormone-Releasing Hormone on Orthotopic and Intraosseous Growth and Invasiveness of PC-3 Human Prostate Cancer in Nude Mice

Available to Purchase
Anton Stangelberger, Andrew V. Schally, Jozsef L. Varga, Marta Zarandi, Karoly Szepeshazi, Patricia Armatis, Gabor Halmos
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 49–57.
https://doi.org/10.1158/1078-0432.49.11.1
Published: 21 January 2005
View articletitled, Inhibitory Effect of Antagonists of Bombesin and Growth Hormone-Releasing Hormone on Orthotopic and Intraosseous Growth and Invasiveness of PC-3 Human Prostate Cancer in Nude Mice
Open the PDF for Inhibitory Effect of Antagonists of Bombesin and Growth Hormone-Releasing Hormone on Orthotopic and Intraosseous Growth and Invasiveness of PC-3 Human Prostate Cancer in Nude Mice in another window
Journal Articles

Preclinical Evaluation of Targeted Cytotoxic Luteinizing Hormone-Releasing Hormone Analogue AN-152 in Androgen-Sensitive and Insensitive Prostate Cancers

Available to Purchase
Markus Letsch, Andrew V. Schally, Karoly Szepeshazi, Gabor Halmos, Attila Nagy
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (12): 4505–4513.
Published: 10 October 2003
View articletitled, Preclinical Evaluation of Targeted Cytotoxic Luteinizing Hormone-Releasing Hormone Analogue AN-152 in Androgen-Sensitive and Insensitive Prostate Cancers
Open the PDF for Preclinical Evaluation of Targeted Cytotoxic Luteinizing Hormone-Releasing Hormone Analogue AN-152 in Androgen-Sensitive and Insensitive Prostate Cancers in another window
Journal Articles

Targeted Doxorubicin-containing Luteinizing Hormone-releasing Hormone Analogue AN-152 Inhibits the Growth of Doxorubicin-resistant MX-1 Human Breast Cancers

Available to Purchase
Ana M. Bajo, Andrew V. Schally, Gabor Halmos, Attila Nagy
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3742–3748.
Published: 23 September 2003
View articletitled, Targeted Doxorubicin-containing Luteinizing Hormone-releasing Hormone Analogue AN-152 Inhibits the Growth of Doxorubicin-resistant MX-1 Human Breast Cancers
Open the PDF for Targeted Doxorubicin-containing Luteinizing Hormone-releasing Hormone Analogue AN-152 Inhibits the Growth of Doxorubicin-resistant MX-1 Human Breast Cancers in another window
Journal Articles

Targeting of Cytotoxic Somatostatin Analog AN-238 to Somatostatin Receptor Subtypes 5 and/or 3 in Experimental Pancreatic Cancers

Available to Purchase
Karoly Szepeshazi, Andrew V. Schally, Gabor Halmos, Baodong Sun, Francine Hebert, Balazs Csernus, Attila Nagy
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (9): 2854–2861.
Published: 01 September 2001
View articletitled, Targeting of Cytotoxic Somatostatin Analog AN-238 to Somatostatin Receptor Subtypes 5 and/or 3 in Experimental Pancreatic Cancers
Open the PDF for Targeting of Cytotoxic Somatostatin Analog AN-238 to Somatostatin Receptor Subtypes 5 and/or 3 in Experimental Pancreatic Cancers in another window
Journal Articles

Effective Treatment of Metastatic MDA-MB-435 Human Estrogen-independent Breast Carcinomas with a Targeted Cytotoxic Analogue of Luteinizing Hormone-releasing Hormone AN-207

Available to Purchase
Ioulia Chatzistamou, Andrew V. Schally, Attila Nagy, Patricia Armatis, Karoly Szepeshazi, Gabor Halmos
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 4158–4165.
Published: 01 October 2000
View articletitled, Effective Treatment of Metastatic MDA-MB-435 Human Estrogen-independent Breast Carcinomas with a Targeted Cytotoxic Analogue of Luteinizing Hormone-releasing Hormone AN-207
Open the PDF for Effective Treatment of Metastatic MDA-MB-435 Human Estrogen-independent Breast Carcinomas with a Targeted Cytotoxic Analogue of Luteinizing Hormone-releasing Hormone AN-207 in another window
Journal Articles

Regression of U-87 MG Human Glioblastomas in Nude Mice after Treatment with a Cytotoxic Somatostatin Analog AN-238

Available to Purchase
Hippokratis Kiaris, Andrew V. Schally, Attila Nagy, Baodong Sun, Karoly Szepeshazi, Gabor Halmos
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 709–717.
Published: 01 February 2000
View articletitled, Regression of U-87 MG Human Glioblastomas in Nude Mice after Treatment with a Cytotoxic Somatostatin Analog AN-238
Open the PDF for Regression of U-87 MG Human Glioblastomas in Nude Mice after Treatment with a Cytotoxic Somatostatin Analog AN-238 in another window